SEC Form 4 · accession 0001209191-16-115074
Neos Therapeutics, Inc. · NEOS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
David J Collier
10% Owner
Presidio Partners 2007, L.P.
10% Owner
James F Watson
10% Owner
Presidio Partners 2007 GP, L.P.
10% Owner
Presidio Partners 2007 GP, LLC
10% Owner
Faysal A. Sohail
10% Owner
Period of report
Apr 18, 2016
Accepted (ET)
Apr 20, 2016 · 5:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001467652
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 18, 2016 | S | 4,434 | $10.0996 | D | 1,575,419 | D | |
| Common Stock | Apr 19, 2016 | S | 7,097 | $10.029 | D | 1,568,322 | D | |
| Common Stock | Apr 20, 2016 | S | 8,327 | $9.8841 | D | 1,559,995 | D | |
| Common Stock | Apr 18, 2016 | S | 114 | $10.0996 | D | 40,393 | I | by Presidio Partners 2007 (Parallel), L.P |
| Common Stock | Apr 19, 2016 | S | 182 | $10.029 | D | 40,211 | I | by Presidio Partners 2007 (Parallel), L.P |
| Common Stock | Apr 20, 2016 | S | 213 | $9.8841 | D | 39,998 | I | by Presidio Partners 2007 (Parallel), L.P |
Table II — derivative securities
No Table II lines on this filing.